Logo Logo
Hilfe
Hilfe
Switch Language to English

Schniepp, Roman; Möhwald, Ken und Wuehr, Max (2021): Symptomatische Behandlungsoptionen chronischer, neurologischer Gangstörungen. In: Fortschritte der Neurologie Psychiatrie, Bd. 89, Nr. 5: S. 243-253

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Gait and mobility impairments are common and relevant in patients with chronic neurological disorders. It reduces the health-related quality of life and induces falls with morbidity. Symptomatic treatment options are therefore necessary in order to improve the health status of patients with neurological disorders. By means of a selective literature research focusing on studies with specific gait-related outcome measures. We discuss the differential treatment options for (1) hypokinetic gait disorders (Parkinson's disease, Normal pressure hydrocephalus, vascular encephalopathy), (2) gait unsteadiness with ataxia (sensory and cerebellar ataxia), and (3) gait with spasticity and paresis (due to multiple sclerosis). Therapeutical options for the symptomatic treatment of gait disorders comprise non-pharmacological and pharmacological approaches. Both address the functional domains of locomotion, postural control, modulation and adaptability of gait. Pharmacological options are orientated to pathophysiology of the underlying diseases. Supportive physiotherapeutic interventions offer broader and unspecific options for treatment. Clinical conditions that specifically disturb the execution of locomotion or gait can also be addressed by the provision of physical therapy or supportive devices. Effective options for the symptomatic treatment of patients with neurological gait disorders are available. Applications of options addressing the pathophysiology of the underlying disease, a functional domain-based exercise and physiotherapy program, and the provision of walking aides for specific symptoms that further worsen gait performance can be recommended.

Dokument bearbeiten Dokument bearbeiten